Patents 115show all

  • 65
    C07K - Peptides
  • 62
    A61K - Preparations for medical, dental, or toilet purposes
  • 32
    Y02A - Technologies for adaptation to climate change
  • 8
    B01D - Separation
  • 4
    C12N - Microorganisms or enzymes
  • 3
    G01N - Investigating or analysing materials by determining their chemical or physical properties

Clinical Trials 7show all

3Phase 13Phase 31Phase 2

SEC Filings show all


97
8-K

18
10-Q

7
10-K

4
D

1
S-1

Contact Information

Cambridge, MA
United States

SEC Form D Funding Events

DateOfferedSoldType
2014-12-05$20,000,010$20,000,010Equity, Security to be Acquired
2010-10-13$35,000,000$8,750,000Equity, Security to be Acquired

Key Executives

  • Mark Levin
    Executive Officer, Director
  • David M Berry
    Director
  • Noubar B Afeyan
    Director
  • Cary Pfeffer
    Executive Officer, Director
  • Kim C. Drapkin
    Executive Officer
  • Abbie C. Celniker, Ph.D.
    Executive Officer, Director
  • Gregory D. Perry
    Executive Officer
  • Daniel S. Lynch
    Director
  • David A. Berry
    Executive Officer, Director
  • Paul Chaney
    Director
  • Wendy L. Dixon
    Director
  • Jane V. Henderson
    Director
  • Cary G. Pfeffer
    Director
  • Karen L. Turbridy
    Executive Officer
  • Eric S. Furfine
    Executive Officer